Recent News

• 04.15.2025 - Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
• 04.15.2025 - Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
• 03.18.2025 - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
• 03.18.2025 - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
• 02.07.2025 - Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
• 02.07.2025 - Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
• 01.30.2025 - Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Recent Filings

• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.18.2025 - 4/A Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4/A Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4/A Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4/A Statement of changes in beneficial ownership of securities
• 02.11.2025 - EX-99.1 EX-99.1